NASDAQ:MIRM

Mirum Pharmaceuticals Stock Insider Trading

etoro logo Buy MIRM
*Your capital is at risk
$91.84
-0.335 (-0.363%)
At Close: Jun 03, 2026

Mirum Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -1.73. In total, the insiders bought 1.17M and sold 157.01K MIRM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-1.73
Buy 1.17M shares
Sell 157.01K shares
72% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
Jan 28, 2026

Analysis Breakdown:

  • Weakened by a contradictory negative Insider Power Score.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 01, 2026
Sell
Common Stock
S-Sale
Peetz Christopher
Chief Executive Officer
CEO / President 2 602
Value: $246.3K
Jun 01, 2026
Buy
Common Stock
M-Exempt
Peetz Christopher
Chief Executive Officer
CEO / President 30 000
Value: $88.1K
Jun 01, 2026
Sell
Common Stock
S-Sale
Peetz Christopher
Chief Executive Officer
CEO / President 1 973
Value: $192.5K
Jun 01, 2026
Buy
Employee Stock Option (right to buy)
M-Exempt
Peetz Christopher
Chief Executive Officer
CEO / President 30 000
Value: $88.1K
Jun 01, 2026
Sell
Common Stock
S-Sale
Peetz Christopher
Chief Executive Officer
CEO / President 16 595
Value: $1.58M
Jun 01, 2026
Sell
Common Stock
S-Sale
Peetz Christopher
Chief Executive Officer
CEO / President 6 926
Value: $665.9K
Jun 01, 2026
Sell
Common Stock
S-Sale
Peetz Christopher
Chief Executive Officer
CEO / President 883
Value: $88.0K
Jun 01, 2026
Sell
Common Stock
S-Sale
Peetz Christopher
Chief Executive Officer
CEO / President 1 021
Value: $100.3K
Jun 01, 2026
Sell
Common Stock
S-Sale
Ramasastry Saira
Director
Director 3 977
Value: $397.7K
May 29, 2026
Buy
Common Stock
M-Exempt
Fischer Laurent
Director
Director 3 977
Value: $403.7K
May 29, 2026
Buy
Common Stock
M-Exempt
Ramasastry Saira
Director
Director 3 977
Value: $403.7K
May 29, 2026
Buy
Restricted Stock Units
M-Exempt
Walbert Timothy P
Director
Director 3 977
Value: $403.7K
May 29, 2026
Buy
Common Stock
M-Exempt
Walbert Timothy P
Director
Director 3 977
Value: $403.7K
May 29, 2026
Buy
Common Stock
M-Exempt
Cardon Lon
Director
Director 3 977
Value: $403.7K
May 29, 2026
Buy
Restricted Stock Units
M-Exempt
Cardon Lon
Director
Director 3 977
Value: $403.7K
May 29, 2026
Buy
Restricted Stock Units
M-Exempt
Fischer Laurent
Director
Director 3 977
Value: $403.7K
May 29, 2026
Buy
Restricted Stock Units
M-Exempt
Ramasastry Saira
Director
Director 3 977
Value: $403.7K
May 15, 2026
Buy
Stock Option (right to buy)
M-Exempt
Ramasastry Saira
Director
Director 2 000
Value: $47.0K
May 15, 2026
Sell
Common Stock
S-Sale
Ramasastry Saira
Director
Director 2 000
Value: $218.9K
May 15, 2026
Buy
Common Stock
M-Exempt
Ramasastry Saira
Director
Director 2 000
Value: $47.0K
Apr 15, 2026
Sell
Common Stock
S-Sale
Ramasastry Saira
Director
Director 2 000
Value: $193.8K
Apr 15, 2026
Buy
Stock Option (right to buy)
M-Exempt
Ramasastry Saira
Director
Director 2 000
Value: $47.0K
Apr 15, 2026
Buy
Common Stock
M-Exempt
Ramasastry Saira
Director
Director 2 000
Value: $47.0K
Mar 16, 2026
Sell
Common Stock
S-Sale
Howe Jolanda
SVP, Global Controller
Officer 4 732
Value: $435.2K
Mar 16, 2026
Sell
Common Stock
S-Sale
Quan Joanne
Chief Medical Officer
Officer 7 287
Value: $670.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT MIRUM PHARMACEUTICALS, INC.
Mirum Pharmaceuticals
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment o...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE